Chart for IPO-INTA.NS


Intas Pharmaceuticals, Ltd. manufactures pharmaceutical products. The Company offers pharmaceuticals products for the segments in neurology, psychiatry, cardiology, diabetology, gastroenterology, urology, ophthalmology, animal healthcare, oncology, biotechnology and orthopaedic. The Company manufactures cytotoxic products. The... (more)
No analyst recommendations are available for IPO-INTA.NS.


Beta: --
Market Cap (Mil.): --
Shares Outstanding (Mil.): 103.48
Dividend: --
Yield (%): --


  IPO-INTA.NS Industry Sector
P/E (TTM): -- 38.36 38.84
EPS (TTM): 20.59 -- --
ROI: 16.15 18.99 18.26
ROE: 34.59 19.74 19.12
Search Stocks

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
Provider: GlobalData
Provider: GlobalData
Provider: GlobalData
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks